Bacteriotherapy and Biohybrid Systems


The group is interested in research of the natural potential of microbiota, and development on its basis biohybrid systems for human health preservation and disease treatment. 

The group develops 
- complex approaches to the correction of microbiota based on the author's constantly updated database on the mechanisms of microorganisms action on the human body; 
- genetically engineered probiotic strains for health correction (probiotic for colorectal cancer treatment, probiotic for dental enamel restoration and others);
- bacteria-based biohybrid composites for microbiota correction and bacterial inflammation therapy (antimicrobial materials for regeneration and wound healing, restoration of oral microflora, female reproductive system);
- new bioactive compounds from microbiota (new metabolic stimulant from bacteria, new antimicrobial molecules)


Lab news